Sandbox:risk: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{familytree/start |summary=PE diagnosis Algorithm.}} {{familytree | | | | | | | | | |,|-| A01 | | | | |A01= }} {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | |...") |
No edit summary |
||
| (9 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | {{familytree | | | | | | | | |,|-| A01 | | | | |A01= | ||
{{familytree | <div style="width: 20em; padding:0em;text-align:left"> | ||
{{familytree | *'''INNS stage 2A/2B, Stage 3 , Stage 4 or Stage 4S'''<br> | ||
{{familytree | *'''Irrespective of age'''<br> | ||
{{familytree | *'''Irrespective of grade'''<br> | ||
{{familytree | *'''''MYCN'' amplified'''</div>}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | |)|-| B01 | | | | ||B01=<div style="width: 20em; padding:0em;text-align:left"> | |||
*'''INSS stage 3'''<br> | |||
*'''>547 days of age'''<br> | |||
*'''Unfavorable histology'''<br> | |||
*'''''MYCN'' not amplified'''</div>}} | |||
{{familytree | | | | | C01 |-|(| | | | | |C01=<div style="width: 20em; padding:1em;text-align:center">'''Intermediate risk neuroblastoma patients (group 2)'''</div> | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | |)|-| C02 | | | | | | |C02=<div style="width: 20em; padding:0em;text-align:left"> | |||
*'''INNS stage 4'''<br> | |||
*'''365-547 days of age'''<br> | |||
*'''Unfavorable histology'''<br> | |||
*'''DNA index=1'''<br> | |||
*'''''MYCN'' not amplified'''</div>}} | |||
{{familytree | | | | | | | | |!| | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | |`|-| C02 | | | | | | |C02=<div style="width: 20em; padding:0em;text-align:left"> | |||
*'''Symptomatic INNS stage 4'''<br> | |||
*'''>547 days of age'''<br> | |||
*'''Irrespective grade'''<br> | |||
*'''Irrespective ''MYCN'' amplification state'''</div>}} | |||
{{familytree/end}} | |||
* '''High risk neuroblastoma patients''' include: | |||
:* Patients with stage 2A/2B, 3, 4, or 4S tumor, irrespective of the age, irrespective of the grade, ''MYCN'' amplified | |||
:* Patients with stage 3 tumor, ≥ 547 days of age, unfavorable histology, ''MYCN'' not amplified | |||
:* Patients with stage 4 tumor, 365-547 days of age, unfavorable histology, DNA index=1, ''MYCN'' not amplified | |||
:* Patients with stage 4 tumor, >547 days of age, irrespective the grade, ''MYCN'' amplification state | |||
Latest revision as of 03:06, 10 October 2015
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Intermediate risk neuroblastoma patients (group 2) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
- High risk neuroblastoma patients include:
- Patients with stage 2A/2B, 3, 4, or 4S tumor, irrespective of the age, irrespective of the grade, MYCN amplified
- Patients with stage 3 tumor, ≥ 547 days of age, unfavorable histology, MYCN not amplified
- Patients with stage 4 tumor, 365-547 days of age, unfavorable histology, DNA index=1, MYCN not amplified
- Patients with stage 4 tumor, >547 days of age, irrespective the grade, MYCN amplification state